Treovir, Inc.
Home - Treovir Inc.
Bala Cynwyd, United States · Founded 2020
- Headquarters
- Bala Cynwyd, Pennsylvania
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- treovir.com
About
Treovir is a biopharmaceutical company developing G207, a targeted oncolytic HSV immunotherapy for recurrent glioblastoma and pediatric glioma. G207 has received FDA Fast Track and orphan product designations. In 2024, Treovir launched a Phase 2 registration study that, if successful, would make G207 the first-ever approved therapy for pediatric glioma.
Summary
Treovir, Inc. is a Biotech company based in Bala Cynwyd, United States, founded in 2020.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/treovir-inc"><img src="https://indexed.vc/api/badge/company/treovir-inc" alt="Treovir, Inc. on Indexed.vc" width="260" height="76" /></a>